Age- and hypertension-induced changes in abnormal contractions in rat aorta

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 6, 2002, Pages 930-937

  Abeywardena, Mahinda Y ^a   Jablonskis, Lina T ^a   Head, Richard J ^a  

^a CSIRO   (Australia)

Author keywords

Aging; Free radicals; Prostaglandin endoperoxides; Spontaneously hypertensive rat; Thromboxane; Vascular contractions

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ESCULETIN; FREE RADICAL; IBUPROFEN; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE; OZAGREL; PROSTAGLANDIN ENDOPEROXIDE; THROMBOXANE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL TONE; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HYPERTENSION; LIPID OXIDATION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; ANIMAL; AORTA; DRUG EFFECT; DRUG INTERACTION; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASOCONSTRICTION; WISTAR KYOTO RAT;

AGING; ANIMALS; AORTA; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; HYPERTENSION; MALE; MUSCLE, SMOOTH, VASCULAR; PROSTAGLANDIN ENDOPEROXIDES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VASOCONSTRICTION;

EID: 0036890888     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200212000-00015     Document Type: Article

References (29)

1. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993;22:S1-14.
2. Drexler H. Factors involved in the maintenance of endothelial function. Am J Cardiol 1998;82:3S-4S.
3. Noll G, Luscher TF. The endothelium in acute coronary syndromes. Eur Heart J 1998;19:C30-8.
4. Luscher TF, Tanner FC, Tschudi MR, et al. Endothelial dysfunction in coronary artery disease. Ann Rev Med 1993;44:395-418.
5. Cardillo C, Panza JA. Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension. Vasc Med 1998;3:138-44.
6. Laight DW, Carrier MJ, Anggard EE. Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy. Diabetes Metab Res Rev 1999;15:274-82.
7. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Rad Biol 1993;16:383-91.
8. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension 1989;13:859-64.
9. 2 as an endothelium-derived contracting factor and its interaction with endothelium-derived nitric oxide. J Hypertens 1991;9:729-36.
10. Dyer SM, Taylor DA, Bexis S, et al. Identification of a nonendothelial cell thromboxane-like constrictor response and its interaction with the renin-angiotensin system in the aorta of spontaneously hypertensive rats. J Vasc Res 1994;31:52-60.
11. Abeywardena MY, Head RJ. Vascular protective actions of natural antioxidants. In: Packer L, Traber MG, Xin W, eds. Natural Antioxidants: Molecular Mechanisms and Health Effects. Champaign, IL: AOCS Press, 1996:584-94.
12. Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol 1996;20:443-8.
13. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of ageing. Proc Natl Acad Sci U S A 1993;90:7915-22.
14. Gey KF. Ten-year retrospective on the antioxidant hypothesis of arthrosclerosis: Threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. Nutr Biochem 1995;6:206-36.
15. Hamilton CA, Brosnan MJ, McIntyre M, et al. Superoxide excess in hypertension and aging: A common cause of endothelial dysfunction. Hypertension 2001;37:529-34.
16. Patrono C, Fitzgerald GA. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 1997;17:2309-15.
17. Laight DW, Carrier MJ, Anggard EE. Antioxidants, diabetes, and endothelial dysfunction. Cardiovasc Res 2000;47:457-64.
18. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circulation 1980;47:1-9.
19. 2 receptor blockade. J Pharmacol Exp Ther 1993;266:511-17.
20. Hanel AM, Lands WEM. Modification on anti-inflammatory drug effectiveness by ambient lipid peroxides. Biochem Pharmacol 1982;30:3307-11.
21. Kulmacz RJ, Palmer G, Tsai AL. Prostaglandin H synthase: Pertubation of the tyrosyl radical as a probe of anticyclooxygenase agents. Mol Pharmacol 1991;40:833-7.
22. Jameson M, Dai FX, Luscher T, et al. Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension. Hypertension 1993;21:280-8.
23. Tomasian D, Keaney JF, Vita JA. Antioxidants and the bioactivity of endothelium-derived nitric oxide. Cardiovasc Res 2000;47:426-35.
24. Abeywardena MY, Head RJ. Modulation of blood vessel function by dietary antioxidants in the spontaneously hypertensive rat. In: Ong ASH, Nikki E, Packer L, eds. Nutrition, Lipids, Health, and Disease. Champaign, IL: AOCS Press, 1995:139-50.
25. Beswick RA, Dorrance AM, Leite R, et al. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 2001;38:1107-11.
26. Fukunaga M, Makita N, Roberts LJ 2nd, et al. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 1993;264:C1619-24.
27. Koga T, Takata Y, Kobayashi K, et al. Age and hypertension promote endothelium-dependent contractions to acetylcholine in the aorta of the rat. Hypertension 1989:14;542-8.
28. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension 1990:15;475-81.
29. Gaziano JM. Antioxidants and cardiovascular disease. In: Keaney JF, ed. Oxidative Stress and Vascular Disease. Boston: Kluwer, 1999:245-58.